Drastic Response of Rechallenge of Nivolumab in a Patient with NSCLC Who Progressed on the First Nivolumab Treatment.
J Thorac Oncol
; 15(1): e20-e22, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31864556
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Antineoplastic Agents, Immunological
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
J Thorac Oncol
Year:
2020
Document type:
Article